United States of America based
We are committed to developing safe and effective vaccines against infectious diseases that address important unmet medical needs to save lives and improve health. We were founded on breakthrough computationally-designed virus-like particle technology, developed at the Institute for Protein Design and exclusively licensed for a variety of infectious disease indications from the University of Washington.
vaccine development infectious disases
TechnologiesAI Companies (Drug Discovery)
No pipelines published yet
No services posted yet